Journal of Affective Disorders
Volume 117, Issue 3 , Pages 162-167 , October 2009

Association between consistent purchase of anticonvulsants or lithium and suicide risk: A longitudinal cohort study from Denmark, 1995–2001

  • Eric G. Smith

      Affiliations

    • Center for Psychopharmacologic Research and Treatment, Department of Psychiatry, University of Massachusetts Medical School, 361 Plantation Street, Worcester, MA 01605, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 781 687 2766; fax: +1 781 687 3106.
    • ,
  • Lars Søndergård

      Affiliations

    • Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Ana Garcia Lopez

      Affiliations

    • Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Per Kragh Andersen

      Affiliations

    • Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark
    • ,
  • Lars Vedel Kessing

      Affiliations

    • Department of Psychiatry, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark

Received 14 August 2008 ,Revised 10 January 2009 ,Accepted 14 January 2009.

References 

  1. Ahrens B, Grof P, Moller HJ, Muller-Oerlinghausen B, Wolf T. Extended survival of patients on long-term lithium treatment. Can. J. Psychiatry. 1995;40:241–246
  2. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34–38 years. J. Affect. Disord. 2002;68:167–181
  3. Arensman E, Kerkhof JF. Classification of attempted suicide: a review of empirical studies, 1963–1993. Suicide Life Threat. Behav. 1996;26:46–67
  4. Baldessarini RB, Tondo L, Hennen J. Effect of lithium treatment and its discontinuation on suicidal behavior in bipolar manic–depressive disorders. J. Clin. Psychiatry. 1999;60(Suppl. 2):77–84
  5. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disorders. 2006;8:625–639
  6. Beautrais AL. Suicides and serious suicide attempts: two populations or one?. Psychol. Med. 2001;31:837–845
  7. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am. J. Psychiatry. 2005;162:1805–1819
  8. Clayton D, Hills M. Statistical Models in Epidemiology. New York, NY: Oxford University Press; 1993;
  9. Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J. Affect. Disord. 2008;107:23–28
  10. Coryell W, Solomon D, Turvey C, Keller M, Leon AC, Endicott J, et al. The long-term course of rapid-cycling bipolar disorder. Arch. Gen. Psychiatry. 2003;60:914–940
  11. Danish National Board of Health (Laegemidelstyrelsen). Medicinal Product Statistics. Available at: www.laegemiddelstyrelsen.dk. Accessed December 13, 2007.
  12. Danish National Board of Health (Sundhedsstyrelsen). Cause of Death in Denmark. Available at: www.sundhedsstyrelsen.dk. Accessed December 13, 2007.
  13. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:1467–1473
  14. Heeringen KV. The suicidal process and related concepts. In:  Heeringen KV editors. Understanding Suicidal Behaviour: The Suicidal Process Approach to Research, Treatment, and Prevention. New York, NY: Wiley Publishers; 2001;p. 3–14
  15. Kerhof JF, Arensman E. Pathway to suicide: the epidemiology of the suicidal process. In:  Heeringen KV editors. Understanding Suicidal Behaviour: The Suicidal Process Approach to Research, Treatment, and Prevention. New York, NY: Wiley Publishers; 2001;p. 15–39
  16. Kessing LV, Sondergard L, Kvist K, Andersen PK. Suicide risk in patients treated with lithium. Arch. Gen. Psychiatry. 2005;62:860–866
  17. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology. 2000;42(Suppl. 1):2–10
  18. Malig C. (December) The Civil Registration System in Denmark. Bethesda, MD: International Institute for Vital Registration and Statistics; 1996;
  19. Muller-Oerlinghausen B, Muser-Causmann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J. Affect. Disord. 1992;25:261–270
  20. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium treatment. Pharmacopsychiatry. 1995;28:8–13
  21. Schou M. The effect of prophylactic lithium treatment on mortality and suicidal behavior: a review for clinicians. J. Affect. Disord. 1998;50:253–259
  22. Schou M, Weeke A. Did manic depressive patients who commit suicide receive prophylactic or continuation treatment at that time?. Br. J. Psychiatry. 1988;324–327
  23. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15
  24. Sondergard L, Kvist K, Andersen PK, Kessing LV. Do antidepressants prevent suicide?. Int. Clin. Psychopharmacol. 2006;21:211–218
  25. Sondergard L, Lopez AG, Andersen PK, Kessing LV. Mood-stabilizing pharmacologic treatment in bipolar disorders and risk of suicide. Bipolar Disorders. 2008;10:87–94
  26. Thies-Flechtner K, Muller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacotherapy. 1996;29:103–107
  27. Tondo L, Baldessarini RB. Reduced suicide risk during lithium maintenance treatment. J. Clin. Psychiatry. 2000;61(Suppl. 9):97–104
  28. Yerevanian BI, Koek RJ, Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J. Affect. Disord. 2003;73:223–228
  29. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: lithium, divalproex, and carbamazepine. J. Affect. Disord. 2007;103:5–11
  30. Yerevanian BI, Koek RJ, Mintz J, Akiskal HS. Bipolar pharmacotherapy and suicidal behavior. Part II: the impact of antidepressants. J. Affect. Disord. 2007;103:13–21
  31. Yerevanian BI, Koek RJ, Mintz J, Akiskal HS. Bipolar pharmacotherapy and suicidal behavior. Part II: the impact of antipsychotics. J. Affect. Disord. 2007;103:23–28

PII: S0165-0327(09)00033-0

doi: 10.1016/j.jad.2009.01.013

Journal of Affective Disorders
Volume 117, Issue 3 , Pages 162-167 , October 2009

Article Tools